Long-term Quality of Life After Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review
- PMID: 36103163
- DOI: 10.1001/jamasurg.2022.4249
Long-term Quality of Life After Parathyroidectomy for Primary Hyperparathyroidism: A Systematic Review
Abstract
Importance: Definitive treatment of primary hyperparathyroidism (pHPT) with curative parathyroidectomy has been shown to improve nonspecific neurocognitive symptoms and may improve long-term quality of life (QOL). However, QOL is not currently routinely assessed preoperatively, and as a result, diminished QOL may be overlooked as an indication for surgery.
Objective: To examine results for measures of long-term QOL after parathyroidectomy in patients with pHPT.
Evidence review: A systematic, English-language literature review was performed to assess the long-term association of parathyroidectomy, defined as a minimum of 1-year postoperative follow-up, with QOL in patients with pHPT. We conducted a search of PubMed and Scopus using Medical Subject Heading (MeSH) terms for hyperparathyroidism, parathyroid hormone, parathyroidectomy, hypercalcemia, and quality of life. All relevant literature published between June 1998 and February 15, 2021, was included. Study selection was guided by the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) strategy.
Findings: Thirty-one studies conducted in 14 countries with a minimum of 1 year of follow-up were included, comprising 3298 patients with pHPT (2975 underwent parathyroidectomy; 323 were observed), 5445 age- and sex-matched control participants, and 386 control patients with benign thyroid disease. To assess QOL, 21 studies (68%) used a general tool, the 36-item Short Form Survey (SF-36), and 8 (26%) used the disease-specific tool Parathyroidectomy Assessment of Symptoms (PAS). The remaining studies used a combination of 10 additional QOL tools. The median follow-up period was 1 year (range, 1-10 years). Of the 31 studies, 27 (87%) demonstrated significant score improvement in long-term QOL after parathyroidectomy, including 1 study that showed continued improvement in QOL 10 years after parathyroidectomy. The remaining 4 studies (13%) reported mixed results.
Conclusions and relevance: This systematic review suggests that parathyroidectomy is associated with improved and sustained QOL in patients with pHPT. Patients with pHPT should be screened with a validated QOL tool such as the SF-36 or PAS at the time of diagnosis to guide discussion of these symptoms in the preoperative setting and the potential for long-term improvement after curative parathyroidectomy.
Similar articles
-
Quality of life in patients with primary hyperparathyroidism before and after parathyroidectomy: long term single center experience.BMC Endocr Disord. 2023 Apr 21;23(1):87. doi: 10.1186/s12902-023-01344-z. BMC Endocr Disord. 2023. PMID: 37085858 Free PMC article.
-
Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study.Clin Endocrinol (Oxf). 2019 Jan;90(1):184-191. doi: 10.1111/cen.13865. Epub 2018 Oct 22. Clin Endocrinol (Oxf). 2019. PMID: 30267589
-
Impact of parathyroidectomy on quality of life in primary hyperparathyroidism.Br J Oral Maxillofac Surg. 2024 Sep 30:S0266-4356(24)00252-3. doi: 10.1016/j.bjoms.2024.09.009. Online ahead of print. Br J Oral Maxillofac Surg. 2024. PMID: 39477711
-
Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review.Nephrol Dial Transplant. 2017 Nov 1;32(11):1902-1908. doi: 10.1093/ndt/gfx044. Nephrol Dial Transplant. 2017. PMID: 28402557 Review.
-
The extent of improvement of health-related quality of life as assessed by the SF36 and Paseika scales after parathyroidectomy in patients with primary hyperparathyroidism--a systematic review and meta-analysis.Int J Surg. 2015 Jan;13:245-249. doi: 10.1016/j.ijsu.2014.12.004. Epub 2014 Dec 24. Int J Surg. 2015. PMID: 25542340 Review.
Cited by
-
Management of surgical diseases of Primary Hyperparathyroidism: indications of the United Italian Society of Endocrine Surgery (SIUEC).Updates Surg. 2024 Jun;76(3):743-755. doi: 10.1007/s13304-024-01796-5. Epub 2024 Apr 15. Updates Surg. 2024. PMID: 38622315 Free PMC article. Review.
-
Patient-reported outcome measures for primary hyperparathyroidism: a systematic review of measurement properties.Health Qual Life Outcomes. 2024 Apr 2;22(1):31. doi: 10.1186/s12955-024-02248-9. Health Qual Life Outcomes. 2024. PMID: 38566079 Free PMC article. Review.
-
Thyroid dysfunction and Alzheimer's disease, a vicious circle.Front Endocrinol (Lausanne). 2024 Feb 14;15:1354372. doi: 10.3389/fendo.2024.1354372. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38419953 Free PMC article. Review.
-
Disparities in access to high-volume parathyroid surgeons in the United States: A call to action.Surgery. 2024 Jan;175(1):48-56. doi: 10.1016/j.surg.2023.03.028. Epub 2023 Nov 6. Surgery. 2024. PMID: 37940435
-
Older Patients With Asymptomatic Primary Hyperparathyroidism: Should Criteria for Surgery Be Expanded?J Endocr Soc. 2023 Aug 4;7(9):bvad098. doi: 10.1210/jendso/bvad098. eCollection 2023 Aug 2. J Endocr Soc. 2023. PMID: 37873505 Free PMC article.
LinkOut - more resources
Full Text Sources
